Bioblast Pharma Ltd.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income.
Profit Margin
| Q2 2018 | 0 | -847K |
|---|
ORPN Income Statement (Q2 2018 – Q2 2018)
| Q2 2018 | |
|---|---|
Revenue | |
Revenue | 0 |
Cost of revenue | 79.5K |
Gross profit | -79.5K |
Operating exp. | |
Research and development | 0 |
Selling and marketing | -683K |
Total operating expenses | 79.5K |
Operating income | -842K |
Other income (expenses), net | 3.5K |
Income before tax | -838.5K |
Income tax expense | 8.5K |
Net income | -847K |
Earnings per share | |
Basic EPS | 0 |
Diluted EPS | 0 |